Major Investment: Eli Lilly Pours $364 Million into UK Biotech for Obesity Research
8 months ago
In a significant development within the biotech industry, pharmaceutical giant Eli Lilly announced an ambitious investment plan, committing a substantial $364 million towards obesity research based in the United Kingdom. This financial injection aims to accelerate innovation and research efforts in combating the escalating global obesity crisis.
Continue reading